Kymera Therapeutics, Inc. - KYMR

  1. All Sectors
  2. Manufacturing
  3. Chemicals
  4. Biological Products, (no Disgnostic Substances)
Latest data: 3/13/2026 10:27:05 PM
EDGAR CIK 0001815442

Buy Breakdown

Total $13,955,348

Sell Breakdown

Total $2,598,929

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
03/04/2026
03/04/2026
Chadwick Jeremy G
Chief Operating Officer
Officer
Sell
-3,919 @ $85.30
($334,272.49)
 73,810 (-5.04%) Direct
03/04/2026
03/04/2026
Gollob Jared
Chief Medical Officer
Officer
Sell
-4,895 @ $85.30
($417,521.08)
 117,134 (-4.01%) Direct
03/04/2026
03/04/2026
Jacobs Bruce N.
Chief Financial Officer
CFO
Sell
-4,895 @ $85.30
($417,521.08)
 232,588 (-2.06%) Direct
03/02/2026
03/04/2026
Chadwick Jeremy G
Chief Operating Officer
Officer
Sell
-2,039 @ $88.93
($181,321.64)
 77,729 (-2.56%) Direct
03/02/2026
03/04/2026
Gollob Jared
Chief Medical Officer
Officer
Sell
-5,613 @ $88.93
($499,147.54)
 122,029 (-4.40%) Direct
03/02/2026
03/04/2026
Jacobs Bruce N.
Chief Financial Officer
CFO
Sell
-7,576 @ $88.93
($673,709.54)
 237,483 (-3.09%) Direct
06/30/2025
07/01/2025
Bvf Partners L P/Il
Director Other owner
Buy
317,167 @ $44.00
$13,955,348.00
 353,412 (875.06%) Direct
05/23/2025
05/23/2025
Chadwick Jeremy G
Chief Operating Officer
Officer
Sell
-2,575 @ $29.30
($75,435.65)
 66,420 (-3.73%) Direct